142 related articles for article (PubMed ID: 7795834)
1. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
Lasser VI; Raczynski JM; Stevens VJ; Mattfeldt-Beman MK; Kumanyika S; Evans M; Danielson E; Dalcin A; Batey DM; Belden LK
Ann Epidemiol; 1995 Mar; 5(2):156-64. PubMed ID: 7795834
[TBL] [Abstract][Full Text] [Related]
2. Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
Hebert PR; Bolt RJ; Borhani NO; Cook NR; Cohen JD; Cutler JA; Hollis JF; Kuller LH; Lasser NL; Oberman A
Ann Epidemiol; 1995 Mar; 5(2):130-9. PubMed ID: 7795831
[TBL] [Abstract][Full Text] [Related]
3. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
Appel LJ; Hebert PR; Cohen JD; Obarzanek E; Yamamoto M; Buring J; Stevens V; Kirchner K; Borhani NO
Ann Epidemiol; 1995 Mar; 5(2):149-55. PubMed ID: 7795833
[TBL] [Abstract][Full Text] [Related]
4. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group.
Whelton PK; Kumanyika SK; Cook NR; Cutler JA; Borhani NO; Hennekens CH; Kuller LH; Langford H; Jones DW; Satterfield S; Lasser NL; Cohen JD
Am J Clin Nutr; 1997 Feb; 65(2 Suppl):652S-660S. PubMed ID: 9022561
[TBL] [Abstract][Full Text] [Related]
6. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
Hollis JF; Satterfield S; Smith F; Fouad M; Allender PS; Borhani N; Charleston J; Hirlinger M; King N; Schultz R
Ann Epidemiol; 1995 Mar; 5(2):140-8. PubMed ID: 7795832
[TBL] [Abstract][Full Text] [Related]
7. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP).
Cook NR; Cutler JA; Obarzanek E; Buring JE; Rexrode KM; Kumanyika SK; Appel LJ; Whelton PK
BMJ; 2007 Apr; 334(7599):885-8. PubMed ID: 17449506
[TBL] [Abstract][Full Text] [Related]
8. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group.
Stevens VJ; Corrigan SA; Obarzanek E; Bernauer E; Cook NR; Hebert P; Mattfeldt-Beman M; Oberman A; Sugars C; Dalcin AT
Arch Intern Med; 1993 Apr; 153(7):849-58. PubMed ID: 8466377
[TBL] [Abstract][Full Text] [Related]
9. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group.
Whelton PK; Appel LJ; Espeland MA; Applegate WB; Ettinger WH; Kostis JB; Kumanyika S; Lacy CR; Johnson KC; Folmar S; Cutler JA
JAMA; 1998 Mar; 279(11):839-46. PubMed ID: 9515998
[TBL] [Abstract][Full Text] [Related]
10. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.
Stevens VJ; Obarzanek E; Cook NR; Lee IM; Appel LJ; Smith West D; Milas NC; Mattfeldt-Beman M; Belden L; Bragg C; Millstone M; Raczynski J; Brewer A; Singh B; Cohen J;
Ann Intern Med; 2001 Jan; 134(1):1-11. PubMed ID: 11187414
[TBL] [Abstract][Full Text] [Related]
11. Trials of hypertension prevention. Phase I design.
Satterfield S; Cutler JA; Langford HG; Applegate WB; Borhani NO; Brittain E; Cohen JD; Kuller LH; Lasser NL; Oberman A
Ann Epidemiol; 1991 Aug; 1(5):455-71. PubMed ID: 1669525
[TBL] [Abstract][Full Text] [Related]
12. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II.
Hunt SC; Cook NR; Oberman A; Cutler JA; Hennekens CH; Allender PS; Walker WG; Whelton PK; Williams RR
Hypertension; 1998 Sep; 32(3):393-401. PubMed ID: 9740601
[TBL] [Abstract][Full Text] [Related]
13. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial.
Appel LJ; Espeland M; Whelton PK; Dolecek T; Kumanyika S; Applegate WB; Ettinger WH; Kostis JB; Wilson AC; Lacy C
Ann Epidemiol; 1995 Mar; 5(2):119-29. PubMed ID: 7795830
[TBL] [Abstract][Full Text] [Related]
14. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I.
JAMA; 1992 Mar; 267(9):1213-20. PubMed ID: 1586398
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.
He J; Whelton PK; Appel LJ; Charleston J; Klag MJ
Hypertension; 2000 Feb; 35(2):544-9. PubMed ID: 10679495
[TBL] [Abstract][Full Text] [Related]
16. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Hypertension Prevention Trial Research Group.
Arch Intern Med; 1990 Jan; 150(1):153-62. PubMed ID: 2404477
[TBL] [Abstract][Full Text] [Related]
17. The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group.
Svetkey LP; Sacks FM; Obarzanek E; Vollmer WM; Appel LJ; Lin PH; Karanja NM; Harsha DW; Bray GA; Aickin M; Proschan MA; Windhauser MM; Swain JF; McCarron PB; Rhodes DG; Laws RL
J Am Diet Assoc; 1999 Aug; 99(8 Suppl):S96-104. PubMed ID: 10450301
[TBL] [Abstract][Full Text] [Related]
18. Dietary sodium reduction for hypertension prevention and treatment.
Elmer PJ; Grimm RH; Flack J; Laing B
Hypertension; 1991 Jan; 17(1 Suppl):I182-9. PubMed ID: 1987001
[TBL] [Abstract][Full Text] [Related]
19. Stress management intervention for primary prevention of hypertension: detailed results from Phase I of Trials of Hypertension Prevention (TOHP-I).
Batey DM; Kaufmann PG; Raczynski JM; Hollis JF; Murphy JK; Rosner B; Corrigan SA; Rappaport NB; Danielson EM; Lasser NL; Kuhn CM
Ann Epidemiol; 2000 Jan; 10(1):45-58. PubMed ID: 10658688
[TBL] [Abstract][Full Text] [Related]
20. Weight change and mortality: Long-term results from the trials of hypertension prevention.
Cook NR; Appel LJ; Whelton PK
J Clin Hypertens (Greenwich); 2018 Dec; 20(12):1666-1673. PubMed ID: 30390361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
